UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052872
Receipt number R000060337
Scientific Title Registry and follow-up study regarding medical and social conditions and outcomes of hospitalized heart failure patients: Multi-center survey in Hiroshima Heart Health Promotion Project 2
Date of disclosure of the study information 2023/11/24
Last modified on 2024/11/22 09:08:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Registry and follow-up study regarding medical and social conditions and outcomes of hospitalized heart failure patients: Multi-center survey in Hiroshima Heart Health Promotion Project 2

Acronym

REAL-HF 2

Scientific Title

Registry and follow-up study regarding medical and social conditions and outcomes of hospitalized heart failure patients: Multi-center survey in Hiroshima Heart Health Promotion Project 2

Scientific Title:Acronym

REAL-HF 2

Region

Japan


Condition

Condition

heart failure

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

1) To elucidate the real medical and social conditions of hospitalized heart failure patients in Japan
2) To identify their real outcomes after discharge

Basic objectives2

Others

Basic objectives -Others

Registration and follow-up

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Occurrence of all cause deaths and all unscheduled readmissions for 12 months after discharge

Key secondary outcomes

1) Clinical characteristics of each patient during the hospitalization, including underlying heart diseases, history of HF, physical activity (ability of independent gait), clinical test data, and treatment methods
2) Information regarding outpatient cardiac rehabilitation and home nursing-care services after discharge


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Adult patients hospitalized with symptomatic heart failure in one of the 7 institutions participating in Hiroshima Heart Health Promotion Project
2) Symptomatic heart failure defined according to Framingham's criteria and/or low output syndrome diagnosed by primary physicians

Key exclusion criteria

none

Target sample size

1400


Research contact person

Name of lead principal investigator

1st name Yukiko
Middle name
Last name Nakano

Organization

Hiroshima University Graduate School of Biomedical and Health Sciences

Division name

Department of Cardiovascular Medicine

Zip code

734-8551

Address

Kasumi 1-2-3 Minami-ku, Hiroshima-shi, Hiroshima

TEL

082-257-5555

Email

nakanoy@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Mizuho
Middle name
Last name Yamaguchi

Organization

Hiroshima University Hospital

Division name

Heart Failure Center

Zip code

734-8551

Address

Kasumi 1-2-3 Minami-ku, Hiroshima-shi, Hiroshima

TEL

082-257-5711

Homepage URL


Email

mizuho46@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University Graduate School of Biomedical and Health Sciences
Department of Cardiovascular Medicine

Institute

Department

Personal name



Funding Source

Organization

Self Procurement

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hiroshima University Hospital Heart Failure Center

Address

Kasumi 1-2-3 Minami-ku, Hiroshima-shi, Hiroshima

Tel

082-257-5711

Email

mizuho46@hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 11 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 10 Month 31 Day

Date of IRB

2024 Year 01 Month 17 Day

Anticipated trial start date

2024 Year 04 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Underlying heart diseases, history of heart failure, physical activity (ability of independent gait), clinical test data, and treatment methods
Occurrence of all cause deaths and all unscheduled readmissions for 12 months after discharge
Information regarding outpatient cardiac rehabilitation and home nursing-care services after discharge


Management information

Registered date

2023 Year 11 Month 22 Day

Last modified on

2024 Year 11 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060337